A Pilot Study of Neoadjuvant Nivolumab, Ipilimumab and Intralesional Oncolytic Virotherapy for HER2-Negative Breast Cancer

dbGaP FAQdbGaP Access Request Video Tutorial

Platforms

dbGaP

View in dbGaP

phs003316.v1.p1

APIs

Consent Codes

HMB-PUB

Focus / Diseases

Breast Neoplasms

Study Design

Clinical Trial

Data Types

RNA-Seq, WXS

Subjects

6